The results of the phase 3 clinical trial of retatrutide are eagerly awaited, as it is expected that over a longer time period its efficacy in weight loss will be even greater
Before the markets opened, the company announced that sales of its obesity medicine, Wegovy, are expected to grow no more than 14% this year
This approach, which we've refined over years, delivers
This economic reality creates pressure throughout the supply chain
When accompanied by metabolic disorders, such as IR and dyslipidaemia, it can lead to hyperlipidaemia, hypertension, metabolic syndrome and diabetes
Weight Loss Advantage: Clinical data show robust weight loss outcomes, aligning with Richards goal of achieving a healthier BMI (17)